
CDC Urges Clinicians to Be Aware of Potential Clade I Mpox Cases From DRC
An outbreak of Clade I mpox virus is currently spreading in the Democratic Republic of the Congo (DRC), and clinicians should be aware of the
An outbreak of Clade I mpox virus is currently spreading in the Democratic Republic of the Congo (DRC), and clinicians should be aware of the
Consensus recommendations for spontaneous coronary artery dissection (SCAD) have been applied inconsistently despite increasing awareness of this condition, according to a meta-analysis. Observational studies showed
The 24-hour news cycle is just as important to medicine as it is to politics, finance, or sports. At MedPage Today, new information is posted
Prenatal infection with common respiratory viruses transmitted from the mother was associated with poorer growth, a prospective cohort study found. Postnatal weight change significantly correlated
Using endoscopic ultrasonography-guided gastroenterostomy (EUS-GE) led to better outcomes in the palliation of malignant gastric outlet obstruction compared with conventional stenting of the duodenum, an
SAN ANTONIO — The investigational Trop2-directed antibody-drug conjugate (ADC) datopotamab deruxtecan (Dato-DXd) continued to best chemotherapy in new results from the phase III randomized TROPION-Breast01
MedPage Today brought together three expert leaders for a virtual roundtable discussion on atopic dermatitis: Moderator Peter Lio, MD, of Northwestern University Feinberg School of
SAN ANTONIO — A maintenance strategy involving checkpoint blockade and a PARP inhibitor after first-line therapy did not improve survival outcomes in unselected patients with
The following is a transcript of the podcast episode: Rachael Robertson: Hey, everybody. Welcome back to MedPod Today, the podcast series where MedPage Today reporters
The FDA approved two cell-based gene therapies, exagamglogene autotemcel (Casgevy) and lovotibeglogene autotemcel (Lyfgenia), for sickle cell disease (SCD), the agency announced. Marking the first